ivWatch is redefining IV therapy safety. The world’s only continuous IV monitoring system is clinically proven to detect infiltration and extravasation events before visible signs appear, ivWatch helps prevent severe IV harm before it happens. Backed by decades of research and clinical validation, ivWatch continuously monitors IV site integrity in high-risk care settings. IV therapy is one of the most common procedures in healthcare, yet studies show up to 50% of IVs fail before treatment is complete, resulting in pain, tissue injury, prolonged hospital stays, and higher costs. Using a non-invasive sensor technology and a predictive algorithm, ivWatch empowers clinical teams to intervene early, improve patient outcomes, reduce liability, and drive cost savings—setting a new standard of care for IV therapy. Our mission is bold: STOP IV HARM. Watch the video and schedule a demo to see ivWatch in action: ivwatch.com/request-a-demo/ #IVSafety #PatientSafety #HealthcareInnovation #MedTech #NursingTechnology #InfiltrationDetection #ContinuousMonitoring #ClinicalExcellence #HospitalSafety #VascularAccess #InfusionTherapy #AvoidableHarm

Can IV site monitoring truly make a difference in neonatal care? Researchers evaluated more than 32,000 neonatal IV catheters and found that continuous optical monitoring was associated with fewer severe infiltration and extravasation events. The study highlights an important conversation around early detection, proactive intervention, and reducing harm before complications escalate. Scroll to see the insights or see the full study in comments section. #PatientSafety #HealthcareTechnology #NICU #Ivinfiltration #IVextravasation Read more: ivwatch.com/2025/08/14/how-c…

Patient safety doesn't happen by chance. It happens when committed healthcare professionals come together to challenge the status quo. That's why the ivWatch team is continuously engaging with hospitals, supporting clinical teams, and advocating for a more proactive approach to IV therapy safety. Every visit, every conversation, and every partnership brings us one step closer to eliminating avoidable IV harm. #ivWatch #PatientSafety #IVTherapy #ThoughtLeadership #HealthcareExcellence #MedTech

Patient care doesn't pause during shift changes. With ivWatch, clinicians can quickly review IV history, documented events, and assessment trends, providing greater visibility into what happened between bedside visits. Learn more about how continuous IV therapy monitoring can assist your clinical teams: ivwatch.com/ #IVWatch #PatientSafety #IVTherapy #IVSafety

Across the country, our team is meeting with nurses, clinical leaders, and healthcare teams to discuss one important goal: preventing avoidable IV harm before it happens. These conversations drive innovation, strengthen partnerships, and help us continue advancing safer IV therapy practices. We're proud to be part of the solution. #PatientSafety #IVTherapy #NursingLeadership #ClinicalExcellence #ivWatch

Great companies are built by people who combine expertise with purpose. Since joining ivWatch in 2023, Helen Stephens has helped drive our international growth, advancing IV safety across healthcare systems and bringing our mission to new markets around the world. With three decades of experience spanning bedside nursing, clinical leadership, business development, and medical device innovation, Helen understands both the clinical challenges providers face and the opportunities to improve patient care. As ivWatch continues to expand globally, leaders like Helen are helping turn our vision of safer IV therapy into reality. #Leadership #HealthcareInnovation #IVSafety #MedicalDevices #IVWatch

ivWatch proudly designs, engineers, and manufactures its technology in the United States. By controlling every stage of development and production, we ensure the highest levels of quality, reliability, and innovation in everything we deliver. Behind every device is a dedicated team that believes healthcare can be safer. Their expertise, precision, and passion fuel a mission that has been driving us since day one. American-made innovation. Global impact. Unwavering commitment to patient safety.

The future of IV therapy in healthcare is built on innovation, collaboration, and a relentless commitment to better patient outcomes. This week, Jay Paris and Marissa Marine are representing ivWatch at the CHKD Innovations and Evidence-Based Practice Conference, engaging with clinicians, researchers, and healthcare leaders who are advancing the standards of care for children. Every conversation, every insight, and every innovation brings us one step closer to safer care and better outcomes for patients everywhere. We're honored to be part of the discussion. Thank you to Chkd Health Center and Macon & Joan Brock Virginia Health Sciences at Old Dominion University for bringing together leaders committed to excellence in pediatric healthcare.

Listening to clinicians has always guided our innovation. Our latest FDA 510(k) submission for SmartTouch+ reflects a focused effort to expand the capabilities of continuous IV monitoring to peripheral IV therapies that infuse white opaque fluids such as TPN and propofol. Learn how ivWatch is working to help clinicians gain greater visibility into potential IV complications and advance patient safety across more care settings. Read the full story: innovate757.org/2026/09/10/i…

Periodic monitoring of IV sites is not enough. In today’s care environments, clinicians are managing high patient volumes and constant demands, making it challenging to identify IV failures at their earliest stages. The gaps between assessments can leave opportunities for complications to progress before they become visible. This isn’t about effort. It’s about having the right support to see what intermittent checks can miss. It’s time to equip clinical teams with better tools for continuous visibility, earlier detection, and safer IV care. #IVSafety #PatientSafety #InfusionTherapy #NursingLeadership #HarmPrevention #HealthcareInnovation

Four stories. Four lives forever changed. Not by disease. Not by diagnosis. By an IV complication that wasn't caught soon enough. A newborn. A child. An adult. A parent. IV harm doesn't discriminate. At ivWatch, our mission is simple and urgent: Make preventable IV injuries a thing of the past. Because behind every statistic is a person whose life was changed in an instant. Jack: ivwatch.com/2020/06/04/patie… Everly:ivwatch.com/2020/06/04/patie… Barby: ivwatch.com/2020/06/04/patie… Melissa:ivwatch.com/2024/10/03/a-pre… #ivWatch #PatientSafety #HealthcareTechnology #EveryPatientMatters

"It's just an IV.” Until it costs someone two fingers. Until it requires 25+ surgeries. Until a mother loses years of her life fighting an injury that should never have happened. Melissa Williams went in for routine surgery and left with an IV injury that would permanently change her future. One IV. One missed warning sign. A lifetime of consequences. At ivWatch, we believe preventable IV harm is unacceptable. Because behind every injury is a person, a family, and a life forever changed. It's never "just an IV.” Read more: ivwatch.com/2024/10/03/a-pre… #PatientSafety #ivWatch #IVTherapy #Extravasation #HealthcareInnovation #PreventableHarm #EveryPatientMatters

What if clinicians could identify IV infiltrations and extravasations associated with white-opaque infusions before they become visible? ivWatch has submitted a 510(k) to the FDA for our new SmartTouch+™ Sensor, designed to expand IV monitoring capabilities to include infiltration and extravasation events associated with both clear and white-opaque fluids, including TPN, propofol, and other lipid-based solutions. It’s another step toward our mission to reduce preventable IV harm and help clinicians intervene earlier, when patients are most vulnerable. Read more: ivwatch.com/2026/08/14/ivwat… SmartTouch+™ is patent pending and under FDA review. Not yet FDA cleared or available for commercial sale in the United States. #IVSafety #InfusionSafety #PatientSafety #VesicantAwareness #IVinfiltration #IVextravasation

Protecting patients across the continuum of care requires unwavering vigilance. During our visit with King’s College Hospital London, Dubai, we had the opportunity to learn more about their commitment to patient safety as the first hospital in the UAE to implement ivWatch across multiple clinical areas, including the NICU, PICU/Paediatrics, Day Unit/Oncology, and Emergency Department. From the smallest and most vulnerable neonatal patients to individuals receiving chemotherapy, early detection and timely intervention can play an important role in helping clinicians reduce the risk of severe tissue injury during IV therapy. We are proud to support teams dedicated to delivering safe, compassionate care at every stage of the patient journey.

In the United States alone, over 400 million short peripheral intravenous catheters are inserted annually. Approximately 56 million of these individuals suffer from infiltration and extravasation injuries.¹ Early detection technology identifies changes in the tissue near the IV insertion site, which is beyond the capability of the human eye. Advocate for your patients and be the reason millions are safe from severe IV injuries. Fight for clinically viable, proven technology. 1. 𝘛𝘩𝘦 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘌𝘤𝘰𝘯𝘰𝘮𝘪𝘤 𝘉𝘶𝘳𝘥𝘦𝘯𝘴 𝘰𝘧 𝘐𝘯𝘧𝘪𝘭𝘵𝘳𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘌𝘹𝘵𝘳𝘢𝘷𝘢𝘴𝘢𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩 𝘗𝘦𝘳𝘪𝘱𝘩𝘦𝘳𝘢𝘭 𝘐𝘯𝘵𝘳𝘢𝘷𝘦𝘯𝘰𝘶𝘴 𝘊𝘢𝘵𝘩𝘦𝘵𝘦𝘳𝘴: 𝘈 𝘊𝘰𝘯𝘵𝘦𝘮𝘱𝘰𝘳𝘢𝘳𝘺 𝘕𝘢𝘳𝘳𝘢𝘵𝘪𝘷𝘦 𝘙𝘦𝘷𝘪𝘦𝘸 (𝘨𝘢𝘷𝘪𝘯𝘱𝘶𝘣𝘭𝘪𝘴𝘩𝘦𝘳𝘴.𝘤𝘰𝘮) #PatientSafety #IVSafety #HealthcareInnovation #InfusionSafety

Continuous infusion site monitoring has earned a place in one of the UK's leading IV therapy standards. The newly released 2026 NIVAS Standards for Infusion Therapy and Vascular Access recognize infusion site surveillance technology as a tool to support earlier detection of infiltration and extravasation events and help improve patient safety. Read why this is an important milestone for the future of IV therapy: ivwatch.com/2026/09/02/nivas… #PatientSafety #InfusionTherapy #VascularAccess #ClinicalInnovation #ivWatch

Safer IV therapy takes all of us. Innovators. Creators. Engineers. Educators. Clinicians. Leaders. Quality and Regulatory. Different expertise. One shared goal: better, safer care for every patient. Grateful for the teams who collaborate, challenge the status quo, and keep moving IV safety forward. Together, progress is possible. #PatientSafety #IVTherapy #TogetherForChange #ivWatch

Severe infiltration injuries are preventable—and costly. Our advanced sensor delivers real-time optical monitoring at 5 readings per second, giving your team the power to detect an infiltration before damage occurs. From the NICU to the OR, this is the clinical oversight your hospital needs to reduce harm, avoid litigation, and lead in patient safety innovation. Invest in technology that safeguards both patients and reputation. #HospitalLeadership #PatientSafety #RiskReduction #VascularAccess #HealthcareInnovation

What if the treatment that is supposed to help patients, harms them? Iron delivery comes in two forms - oral and intravenous. Many patients with iron-deficiency anemia opt for IV iron infusion treatments as they are more effective and tolerable than taking iron orally. However, there are life-altering risks to patients if the iron leaks into the tissue: • IV Iron infusions are administered rapidly, so extravasation symptoms are hard to detect before an injury occurs. • Iron infiltrations leave a permanent orange staining on the skin. • There is no treatment for IV iron injuries, the impact lasts a lifetime. This is a warning to utilize extravasation detection technology and to be vigilant in monitoring IV iron infusions. Learn more from this study: ivwatch.com/2024/11/26/briti… #intravenousiron #IViron #PatientSafety #IVSafety #InfusionSafety #MaternalHealth #IronDeficiency

Real progress in patient safety starts with education. By equipping clinicians with the knowledge and resources they need, healthcare organizations can build confidence, strengthen workflows, and support better outcomes for patients. Thankful for the opportunity to partner with dedicated clinical teams committed to continuous improvement. #IVSafety #PatientSafety #NursingLeadership #ClinicalExcellence #ivWatch

You can't improve what you don't measure. When was the last time your organization looked closely at peripheral IV infiltrations and extravasations? For many health systems, these events are underreported, inconsistently tracked, and difficult to see at the enterprise level. Yet they can impact patient outcomes, nursing workload, operational efficiency, and organizational risk. Our latest article outlines the questions healthcare leaders should be asking to uncover hidden IV safety risks and drive meaningful improvement. Read the article: ivwatch.com/2026/08/14/what-… #PatientSafety #HealthcareQuality #NursingInnovation #HospitalLeadership #IVTherapy